HCWB HCW Biologics Inc

HCW Biologics Extends Massive Rally After Licensing Deal Drives Q1 Profit

HCW Biologics shares rose 8.20% to $1.32 following a Q1 2026 report showing a swing to a $3.47 million net income. The surge is primarily attributed to a $6.5...